Stocktoria

BALCHEM CORP BCPC

Nasdaq · XNAS · stock · Chemicals & Allied Products
Chart by TradingView
8/9
Piotroski F — financial health
6.82
Altman Z″ — distress risk · safe
18.3%
Dividend payout · safe

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$1.0B$154.8M$370.6M$1.3B
2024$953.7M$128.5M$336.2M$1.1B
2023$922.4M$108.5M$302.1M$1.1B
2022$942.4M$105.4M$280.5M$89.5M$938.3M
2021$799.0M$96.1M$243.2M$124.4M$877.0M
2020$703.6M$84.6M$223.9M$118.4M$828.2M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Backus William A.VP & Chief Accounting Officer2026-02-12Tax withheld70$177.49
Miyata HatsukiEVP, CLO, & Secretary2026-02-12Tax withheld181$177.49
van Gunsteren Job LeonardSVP and GM, Specialty Products2026-02-12Tax withheld58$177.49
Harris Theodore LChairman, President & CEO2026-02-12Tax withheld844$177.49
Boned FredericSVP/GM, Human Nutri. & Health2026-02-12Tax withheld203$177.49
Tignor Michael BrentSVP & Chief HR Officer2026-02-12Tax withheld165$177.49
Reid Martin LutherSVP Chief Supply Chain Officer2026-02-12Tax withheld116$177.49
Bengtsson Carl MartinEVP & Chief Financial Officer2026-02-12Tax withheld302$177.49

Why these scores methodology →

Piotroski F-score: 8/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 6.82 (safe)

  • Working capital / assets 0.112
  • Retained earnings / assets 0.665
  • EBIT / assets 0.124
  • Equity / liabilities 2.932

Source: SEC EDGAR filings · CIK 0000009326 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.